InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50
United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Rachna Khosla
13 Aug 2026
SVP, Business Development
Sold after exercise
1,252
$416.43
$521.36K
Nancy A. Grygiel
6 Aug 2026
SVP & CCO
Sold after exercise
1,000
$402.16
$402.16K
Nancy A. Grygiel
6 Aug 2026
SVP & CCO
Sold after exercise
1,970
$402.16
$792.26K
Derek Miller
6 Aug 2026
SVP, Human Resources
Sold after exercise
1,821
$402.54
$733.03K
Derek Miller
6 Aug 2026
SVP, Human Resources
Sold after exercise
2,069
$402.54
$832.86K
Esteban Santos
26 Feb 2026
EVP, Operations
Sold after exercise
24,291
$379.12
$9.21M
Esteban Santos
26 Feb 2026
EVP, Operations
Sold after exercise
30,501
$379.12
$11.56M
Nancy A. Grygiel
20 Nov 2025
SVP & CCO
Sold after exercise
1,639
$337.26
$552.77K
Nancy A. Grygiel
20 Nov 2025
SVP & CCO
Sold after exercise
1,500
$337.26
$505.89K
Show all 15 transactions →

What was left out

Form 4 filings counted 86
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 510,711
History held since 4 Oct 2006